(E)-1-(4-(6-((5-(3-Fluorostyryl)thiazol-2-yl)amino)-2-methylpyrimidin-4-yl)piperazin-1-yl)hex-5-yn-1-one

ID: ALA4642122

PubChem CID: 156016528

Max Phase: Preclinical

Molecular Formula: C26H27FN6OS

Molecular Weight: 490.61

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C#CCCCC(=O)N1CCN(c2cc(Nc3ncc(/C=C/c4cccc(F)c4)s3)nc(C)n2)CC1

Standard InChI:  InChI=1S/C26H27FN6OS/c1-3-4-5-9-25(34)33-14-12-32(13-15-33)24-17-23(29-19(2)30-24)31-26-28-18-22(35-26)11-10-20-7-6-8-21(27)16-20/h1,6-8,10-11,16-18H,4-5,9,12-15H2,2H3,(H,28,29,30,31)/b11-10+

Standard InChI Key:  NRAMCQQQJOMLHN-ZHACJKMWSA-N

Molfile:  

 
     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
   19.1266   -9.4784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1404   -8.6595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8640   -8.2594    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.8737   -7.4404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1744   -7.0157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4507   -7.4117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4306   -8.2364    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.7557   -6.9910    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.7754   -6.1723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0662   -5.7355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3428   -6.1355    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.3329   -6.9602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0374   -7.3841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6436   -5.7107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9253   -6.1079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2202   -5.6801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5020   -6.0772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8010   -5.6496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1018   -5.2290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6601   -4.8918    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.5920   -7.0432    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.6092   -6.2243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9485   -5.7259    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   20.2242   -4.9517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0432   -4.9674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2801   -5.7501    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.7537   -4.2765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1017   -3.5329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6354   -2.8619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9876   -2.1210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5220   -1.4462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7026   -1.5142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3510   -2.2626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8229   -2.9343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5328   -2.3338    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  2  0
  3  4  1  0
  5  4  2  0
  6  5  1  0
  7  6  2  0
  2  7  1  0
  6  8  1  0
  9  8  1  0
 10  9  1  0
 11 10  1  0
 11 12  1  0
 13 12  1  0
  8 13  1  0
 11 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  3  0
 14 20  2  0
 21  4  1  0
 22 21  1  0
 23 22  1  0
 23 24  1  0
 25 24  2  0
 26 25  1  0
 22 26  2  0
 27 24  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 33 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4642122

    ---

Associated Targets(Human)

ABL1 Tclin Cereblon/BCR/ABL (220 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 490.61Molecular Weight (Monoisotopic): 490.1951AlogP: 4.75#Rotatable Bonds: 8
Polar Surface Area: 74.25Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.83CX Basic pKa: 6.49CX LogP: 5.74CX LogD: 5.68
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.36Np Likeness Score: -1.79

References

1. Yang Y, Gao H, Sun X, Sun Y, Qiu Y, Weng Q, Rao Y..  (2020)  Global PROTAC Toolbox for Degrading BCR-ABL Overcomes Drug-Resistant Mutants and Adverse Effects.,  63  (15): [PMID:32657579] [10.1021/acs.jmedchem.0c00967]

Source